AngioDynamics Accounts Payable vs Inventories Analysis
ANGO Stock | USD 6.05 0.07 1.14% |
Trend analysis of AngioDynamics balance sheet accounts such as Total Assets of 533.4 M, Short and Long Term Debt Total of 66.3 M or Other Current Liab of 52.4 M provides information on AngioDynamics' total assets, liabilities, and equity, which is the actual value of AngioDynamics to its prevalent stockholders. By breaking down trends over time using AngioDynamics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
AngioDynamics |
About AngioDynamics Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of AngioDynamics at a specified time, usually calculated after every quarter, six months, or one year. AngioDynamics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of AngioDynamics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which AngioDynamics currently owns. An asset can also be divided into two categories, current and non-current.
AngioDynamics Balance Sheet Chart
AngioDynamics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how AngioDynamics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, AngioDynamics' Other Current Assets are very stable compared to the past year. As of the 12th of May 2024, Non Currrent Assets Other is likely to grow to about 65.6 M, while Common Stock Shares Outstanding is likely to drop about 29.4 M. Add Fundamental
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Total Assets
Total assets refers to the total amount of AngioDynamics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AngioDynamics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Cash And Short Term Investments
Short Term Investments is an account in the current assets section of AngioDynamics balance sheet. This account contains AngioDynamics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by AngioDynamics fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Most indicators from AngioDynamics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AngioDynamics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.At this time, AngioDynamics' Discontinued Operations is very stable compared to the past year. As of the 12th of May 2024, Enterprise Value is likely to grow to about 352.9 M, while Selling General Administrative is likely to drop about 27.5 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 165.7M | 174.2M | 200.4M | 129.6M | Total Revenue | 316.2M | 338.8M | 389.6M | 242.9M |
AngioDynamics fundamental ratios Correlations
Click cells to compare fundamentals
AngioDynamics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AngioDynamics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 38.0M | 38.3M | 39.0M | 39.5M | 45.4M | 29.4M | |
Total Assets | 595.5M | 561.4M | 552.8M | 532.6M | 612.5M | 533.4M | |
Short Long Term Debt Total | 40.8M | 20M | 33.8M | 49.8M | 57.3M | 66.3M | |
Other Current Liab | 2.1M | 38.0M | 21.5M | 43.4M | 49.9M | 52.4M | |
Total Current Liabilities | 51.5M | 57.6M | 74.3M | 83.8M | 96.4M | 48.7M | |
Total Stockholder Equity | 455.9M | 439.5M | 424.5M | 378.3M | 435.0M | 404.2M | |
Property Plant And Equipment Net | 28.3M | 37.1M | 45.0M | 44.4M | 51.0M | 35.0M | |
Net Debt | (13.6M) | (28.2M) | 5.0M | 5.2M | 6.0M | 5.7M | |
Retained Earnings | (100.3M) | (131.9M) | (158.4M) | (210.9M) | (189.8M) | (180.3M) | |
Accounts Payable | 19.1M | 19.6M | 28.0M | 40.4M | 46.5M | 48.8M | |
Cash | 54.4M | 48.2M | 28.8M | 44.6M | 51.3M | 45.7M | |
Non Current Assets Total | 442.6M | 420.6M | 409.4M | 369.1M | 424.5M | 382.2M | |
Other Assets | 5.2M | 3.8M | 11.0M | 49.2M | 56.6M | 59.4M | |
Long Term Debt | 40M | 20M | 25M | 49.8M | 57.3M | 58.7M | |
Cash And Short Term Investments | 54.4M | 48.2M | 28.8M | 44.6M | 51.3M | 61.7M | |
Net Receivables | 31.3M | 35.4M | 52.3M | 52.8M | 60.7M | 38.3M | |
Common Stock Total Equity | 374K | 377K | 380K | 382K | 439.3K | 308.9K | |
Liabilities And Stockholders Equity | 595.5M | 561.4M | 552.8M | 532.6M | 612.5M | 533.4M | |
Non Current Liabilities Total | 88.1M | 64.4M | 53.9M | 70.5M | 81.1M | 80.5M | |
Inventory | 59.9M | 48.6M | 51.4M | 55.3M | 63.6M | 42.5M | |
Other Current Assets | 2.2M | 1.8M | 2.2M | 4.6M | 4.2M | 4.5M | |
Other Stockholder Equity | 557.2M | 567.8M | 581.2M | 593.5M | 682.5M | 424.4M | |
Total Liab | 139.6M | 122.0M | 128.3M | 154.3M | 177.5M | 129.1M | |
Property Plant And Equipment Gross | 28.3M | 37.1M | 96.1M | 44.4M | 51.0M | 37.5M | |
Total Current Assets | 152.9M | 140.9M | 143.3M | 163.5M | 188.1M | 151.2M | |
Accumulated Other Comprehensive Income | (1.3M) | 3.2M | 1.4M | (4.7M) | (5.4M) | (5.2M) | |
Short Term Debt | 836K | 2.4M | 8.8M | 14.8M | 17.0M | 8.5M | |
Intangible Assets | 197.1M | 169.0M | 152.4M | 111.1M | 127.8M | 113.3M | |
Common Stock | 374K | 377K | 380K | 382K | 439.3K | 309.7K | |
Property Plant Equipment | 28.3M | 37.1M | 45.0M | 44.4M | 51.0M | 34.9M | |
Non Currrent Assets Other | 15.6M | 13.2M | (5.1M) | 54.3M | 62.5M | 65.6M | |
Other Liab | 39.6M | 37.1M | 24.2M | 17.4M | 20.0M | 32.6M | |
Good Will | 201.5M | 201.3M | 201.1M | 159.2M | 183.1M | 283.9M | |
Net Tangible Assets | 57.2M | 69.2M | 71.1M | 378.3M | 435.0M | 456.8M | |
Retained Earnings Total Equity | (100.3M) | (131.9M) | (158.4M) | (210.9M) | (189.8M) | (180.3M) | |
Long Term Debt Total | 40M | 20M | 25M | 49.8M | 44.8M | 69.2M | |
Capital Surpluse | 561.9M | 573.5M | 586.9M | 599.2M | 689.1M | 600.4M | |
Deferred Long Term Liab | 24.1M | 20.0M | 16.0M | 12.8M | 14.7M | 14.1M |
Pair Trading with AngioDynamics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.Moving against AngioDynamics Stock
0.6 | ENSG | Ensign Group | PairCorr |
0.53 | STE | STERIS plc | PairCorr |
0.41 | UHS | Universal Health Services | PairCorr |
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for AngioDynamics Stock analysis
When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.80) | Revenue Per Share 8.105 | Quarterly Revenue Growth (0.07) | Return On Assets (0.05) | Return On Equity (0.62) |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.